Nonadherence to antiseizure medications: what have we learned and what can be done next? [0.03%]
抗癫痫药物的不依从：我们已经了解了什么？下一步该怎么做？
Sinaa Al-Aqeel
Sinaa Al-Aqeel
Introduction: Nonadherence to antiseizure medications (ASMs) is associated with increased mortality, morbidity, health care utilization, and costs. Areas ...
Akshay Shetty,Michelle Lee,Julia Valenzuela et al.
Akshay Shetty et al.
Introduction: Introduction of direct acting antivirals (DAA) has transformed treatment of chronic hepatitis C (HCV) and made the elimination of HCV an achievable goal set forward by World Health Organization by 2030. Mult...
Monetary valuation of one year in full capability and health based on demographics, health status, income and well-being [0.03%]
基于人口统计学、健康状况、收入和幸福感的一年完全健康状态的货币价值评估
Mabore Thema,Zsuzsanna Beretzky,Valentin Brodszky
Mabore Thema
Background: Budget constraints in health-care systems have led to the popularity of Cost Effectiveness Thresholds (CET) to achieve efficient allocation of resources. The capability approach has been hailed for its potenti...
Cost-utility of sintilimab plus chemotherapy vs chemotherapy as first-line treatment of advanced gastric or gastroesophageal junction cancer in China [0.03%]
替雷利姆赛博化疗与单纯化疗作为中国晚期胃癌或食管胃结合部癌一线治疗的的成本效用比研究
Wei Li,Li Wan
Wei Li
Objectives: ORIENT-16, a phase III clinical trial conducted at 62 hospitals in China, reported that add-on sintilimab (Sin) to chemotherapy (Chemo) had favorable efficacy (p < 0.05) for patients with advanced HER2-negativ...
Expert review of pharmacoeconomics and outcomes research: high impact articles from 2023 [0.03%]
药物经济学与结果研究专家评论：2023年高影响力文章
Mickaël Hiligsmann,Mitchell P DeKoven,Riddhi Doshi et al.
Mickaël Hiligsmann et al.
Economic burden of type-2 diabetes in Peru: a cost-of-illness study valuing cost differences associated with the level of glycemic control [0.03%]
秘鲁2型糖尿病的经济负担：一项关于血糖控制水平相关成本差异的成本疾病研究
Janice Seinfeld,Alfredo Sobrevilla,María Laura Rosales et al.
Janice Seinfeld et al.
Objectives: Type 2 diabetes mellitus (T2DM) represents an increasing public health problem in Peru. This study aims to estimate the national economic burden of this disease for the public funder, the social security, and ...
The impact of bone turnover marker on medication adherence and the health economics-related consequences [0.03%]
骨代谢标志物对药物依从性及卫生经济学结局的影响研究
Nannan Li,Niklas Rye Jørgensen,Jean-Yves Reginster et al.
Nannan Li et al.
Steven Simoens,Teresa Barcina Lacosta,András Inotai
Steven Simoens
Assessing the economic impact of digital endpoints on medication adherence [0.03%]
评估数字终端对药物依从性经济影响的方法
Ahmad Z Al Meslamani,Nannan Li
Ahmad Z Al Meslamani